Revolution Medicines, Inc. (RVMD) stock
RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
$161.20+1.77 (+1.11%)
Close on Nov 20, 2026Market cap $34.55BP/E –Yield –
Revolution Medicines shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Revolution Medicines's shares outstanding was 211M at Jun 30, 2026. For fiscal 2025 it was 190M, up 13.3% from the year before. The highest annual figure on record is 190M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 190M | +13.3% |
| FY2024 | Dec 31, 2024 | 168M | +48.2% |
| FY2023 | Dec 31, 2023 | 113M | +40.3% |
| FY2022 | Dec 31, 2022 | 81M | +10.7% |
| FY2021 | Dec 31, 2021 | 73M | +32.7% |
| FY2020 | Dec 31, 2020 | 55M | +1879.2% |
| FY2019 | Dec 31, 2019 | 3M | +20.6% |
| FY2018 | Dec 31, 2018 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 211M | +11.8% |
| Q1 FY2026 | Mar 31, 2026 | 198M | +5.3% |
| Q4 FY2025 | Dec 31, 2025 | 195M | +11.7% |
| Q3 FY2025 | Sep 30, 2025 | 189M | +13.4% |
| Q2 FY2025 | Jun 30, 2025 | 189M | +14.2% |
| Q1 FY2025 | Mar 31, 2025 | 188M | +14.2% |
| Q4 FY2024 | Dec 31, 2024 | 174M | +23.1% |
| Q3 FY2024 | Sep 30, 2024 | 167M | +52.7% |
| Q2 FY2024 | Jun 30, 2024 | 165M | +54.5% |
| Q1 FY2024 | Mar 31, 2024 | 165M | +73.7% |
| Q4 FY2023 | Dec 31, 2023 | 141M | +58.5% |
| Q3 FY2023 | Sep 30, 2023 | 109M | +29.0% |
| Q2 FY2023 | Jun 30, 2023 | 107M | +43.9% |
| Q1 FY2023 | Mar 31, 2023 | 95M | +27.9% |
| Q4 FY2022 | Dec 31, 2022 | 89M | +20.9% |
| Q3 FY2022 | Sep 30, 2022 | 85M | +15.2% |
| Q2 FY2022 | Jun 30, 2022 | 74M | +1.2% |
| Q1 FY2022 | Mar 31, 2022 | 74M | +5.3% |
| Q4 FY2021 | Dec 31, 2021 | 74M | +11.2% |
| Q3 FY2021 | Sep 30, 2021 | 74M | +13.3% |
| Q2 FY2021 | Jun 30, 2021 | 73M | +24.9% |
| Q1 FY2021 | Mar 31, 2021 | 70M | +140.4% |
| Q4 FY2020 | Dec 31, 2020 | 66M | +2174.3% |
| Q3 FY2020 | Sep 30, 2020 | 65M | +2212.3% |
| Q2 FY2020 | Jun 30, 2020 | 59M | +2061.2% |
| Q1 FY2020 | Mar 31, 2020 | 29M | +1008.2% |
| Q4 FY2019 | Dec 31, 2019 | 3M | – |
| Q3 FY2019 | Sep 30, 2019 | 3M | – |
| Q2 FY2019 | Jun 30, 2019 | 3M | – |
| Q1 FY2019 | Mar 31, 2019 | 3M | – |
See a number that looks wrong?